Evidence map›Paper›PMID 38688559›Full record

ArticleRNA (New York, N.Y.)2024

Suppression of the

Arianne M Babina, Leif A Kirsebom, Dan I Andersson

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The poly (A) polymeraseFrontiers in microbiology · 2025
    Article
  2. BPP43_05035 is aGut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arianne M BabinaDepartment of Medical Biochemistry and Microbiology arianne.babina@imbim.uu.se arianne.babina@glasgow.ac.uk.ORCID 0000-0002-4635-8396
Leif A KirsebomDepartment of Cell and Molecular Biology, Uppsala University, 751 23 Uppsala, Sweden.ORCID 0000-0002-5092-512X
Dan I AnderssonDepartment of Medical Biochemistry and Microbiology.ORCID 0000-0001-6640-2174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNase P is an essential enzyme found across all domains of life that is responsible for the 5'-end maturation of precursor tRNAs. For decades, numerous studies have sought to elucidate the mechanisms and biochemistry governing RNase P function. However, much remains unknown about the regulation of RNase P expression, the turnover and degradation of the enzyme, and the mechanisms underlying the phenotypes and complementation of specific RNase P mutations, especially in the model bacterium,

Indexed as

Escherichia coliEscherichia coli ProteinsMutationPhenotypeRibonuclease PProtease LaSuppression, GeneticTemperatureEscherichia coli ProteinsLon protein, E coliProtease LaRibonuclease Pgene amplificationLonRNase PRNase Rsuppressor mutation

Identifiers

PMID38688559
PMCPMC11251521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.